Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel + Trastuzumab +/- Lapatinib as Neoadjuvant Treatment for HER2-Positive Breast Cancer
NCT00770809Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2009
- Primary completion
- Jan 2014
- Countries
- 2
01
Overview
A Phase 3 trial of lapatinib in breast cancer, sponsored by National Cancer Institute. Started Feb 2009; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00770809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770809.